Merck & Co diversifies its oncology portfolio further by acquiring VelosBio for $2.75bn

Merck & Co diversifies its oncology portfolio further by acquiring VelosBio for $2.75bn

$56.88

Available Options

merck ppo horizon bcbs
Merck & Co diversifies its oncology portfolio further by acquiring VelosBio for $2.75bn

A total of 5 guests made comments

2026-04-08

Nicely packed, easy to use, and looks just like the pictures.

2026-04-16

The product came exactly as described and was easy to start using.

2026-04-14

The product arrived on time and in perfect condition. It matches the description and seems to be of good quality.

2026-04-15

It’s a functional and practical design for regular use.

2026-04-12

The product is easy to use and seems reliable so far.

Add a review

Your email address will not be published. Required fields are marked

Your rating

Related Products